 | |
- close
- close
|
RELATED WIKI ARTICLES
Medidata Solutions Executives to Lead Sessions During Key Industry Events in October
Business Wire
Oct 02, 2009
Medidata Solutions (Nasdaq: MDSO), a leading global provider of hosted clinical development solutions, today announced that members of its executive team will deliver the following presentations at MAGI's Clinical Research Conference 2009 West, to be held October 4-7, 2009 in San Diego, CA and the 3rd Annual DIA Clinical Forum, to be held October 19-21, 2009 in Nice, France:
|
MAGI's Clinical Research Conference - 2009 West |
||
|
October 5th |
||
| Presentation Title: “Pricing Patterns and Trends” | ||
| Speaker: Lori Shields, Vice President Operations | ||
| Time: 1:30 p.m. ET | ||
|
3rd Annual DIA Clinical Forum |
||
|
October 19th |
||
| Presentation Title: “Structured Protocol Design and the Future of eClinical” | ||
| Speaker: Glen de Vries, President | ||
| Track 1.3, Session 1: Leading Technologies – Part One | ||
| Time: 2 p.m. CET | ||
| Presentation Title: “MHRA Inspection: A Supplier Viewpoint of the Experience” | ||
| Speaker: Earl W. Hulihan, Senior Vice President, Regulatory Compliance | ||
| Track 2, Session 1: Risk Validation & eClinical | ||
| Time: 2 p.m. CET | ||
|
October 20th |
||
| Presentation Title: “An Overview of the Current Status of Computerized Systems in Clinical Research: Current Quality and Data Integrity Concepts Manual” | ||
| Speaker: Earl W. Hulihan, Senior Vice President, Regulatory Compliance (Session Chairperson) | ||
| Track 2, Session 3: Computerized Systems Used in Clinical Research: Best Practices | ||
| Time: 9 a.m. CET | ||
| Presentation Title: “Inspection of an e-CRF Provider - A survivor’s story” | ||
| Speaker: Earl W. Hulihan, Senior Vice President, Regulatory Compliance | ||
| Track 2, Session 4: Audits & Inspections | ||
| Time: 11:00 a.m. CET | ||
| Co-moderator: Earl W. Hulihan | ||
| Track 2, Session 6: Cloud Computing: An Interactive Session | ||
| Time: 4:00 p.m. CET | ||
|
October 21st |
||
| Presentation Title: “Planning for Success in Post-Marketing Studies: Best Practices for Improving Site Retention and Overall Study Results Using Electronic Data Capture Systems” | ||
| Speaker: Patrick Chassaigne, Director, Late Phase Solutions | ||
| Track 1.1, Session 8: Non-Interventional Studies | ||
| Time: 11 a.m. CET | ||
For background information about Medidata executives, please visit http://www.mdsol.com/about/team.htm.
About MAGI
MAGI members represent clinical research sponsors, sites and CROs. MAGI’s objective is to streamline clinical research, starting with a flexible clinical trial model agreement, a database of state and international laws and regulations that affect clinical trial agreements, and educational activities. Norman M. Goldfarb, CRCP, founder and chairman of MAGI, is organizing and chairing the Clinical Research Conference - 2009 West. For more information, please visit www.magiworld.org.
About the DIA Clinical Forum
DIA’s 3rd Annual Clinical Forum hosts new and experienced colleagues in the field of clinical and safety data management, statistics, medical information, medical writing, pharmacovigilance, information technology and validation providing attendees a wide range of educational forums, discussion experiences and solution exploration. In addition to established formats like tutorials and sessions dedicated to the different areas of interest, this event provides attendees the opportunity to meet colleagues from business partner functions to discuss new ideas, interfaces and data streams. For more information, please visit www.diahome.org.
About Medidata Solutions Worldwide
Medidata Solutions (www.mdsol.com) is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers’ clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer®), investigator benchmarking and budgeting (Medidata Grants Manager™), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor™), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave®). Medidata’s diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies.
(c) 2009 Business Wire, Inc., All rights reserved. All of the news releases and other content contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. Any copying or reproduction (other than for an individual user's personal reference), redistribution, reposting or other transmission or communication is expressly prohibited without prior written permission of Business Wire, Inc
| ||||||
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
|
|
